Shanghai HeartCare Medical Technology Corporation Limited (6609.HK)
HKD 29.8
(1.19%)
HKD 29.8
(1.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -126.87 Million CNY | 36.11% |
| 2022 | -198.56 Million CNY | -1.15% |
| 2021 | -196.31 Million CNY | 8.17% |
| 2020 | -213.76 Million CNY | -182.36% |
| 2019 | -75.7 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | -126.87 Million CNY | 36.11% |
| 2023 Q4 | -31.3 Million CNY | 0.0% |
| 2023 Q1 | -32.12 Million CNY | 44.05% |
| 2023 Q2 | -32.12 Million CNY | 0.0% |
| 2023 Q3 | -31.3 Million HKD | 2.56% |
| 2022 Q2 | -42.38 Million CNY | 0.0% |
| 2022 Q4 | -57.42 Million CNY | 0.0% |
| 2022 Q3 | -57.42 Million CNY | -35.47% |
| 2022 FY | -198.56 Million CNY | -1.15% |
| 2022 Q1 | -42.38 Million CNY | -8.06% |
| 2021 Q1 | -41.7 Million CNY | 54.99% |
| 2021 FY | -196.31 Million CNY | 8.17% |
| 2021 Q2 | -52.69 Million CNY | -26.36% |
| 2021 Q3 | -39.22 Million CNY | 25.56% |
| 2021 Q4 | -39.22 Million CNY | 0.0% |
| 2020 Q3 | -92.65 Million CNY | -1333.65% |
| 2020 Q4 | -92.65 Million CNY | 0.0% |
| 2020 FY | -213.76 Million CNY | -182.36% |
| 2020 Q2 | -6.46 Million CNY | 28.09% |
| 2020 Q1 | -8.98 Million CNY | 0.0% |
| 2019 FY | -75.7 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 65.78 Million HKD | 292.87% |